Who are Twinrix™ Junior's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Twinrix™ Adult.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/twinrix-junior.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Twinrix™ Junior — Competitive Intelligence Brief

Twinrix™ Junior (Twinrix™ Junior) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated viral vaccine (combination). Area: Immunology / Infectious Disease.

phase 3 Inactivated viral vaccine (combination) Hepatitis A virus and Hepatitis B surface antigen Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Twinrix™ Junior (Twinrix™ Junior) — GlaxoSmithKline. Twinrix Junior is a combined vaccine that stimulates the immune system to produce antibodies against hepatitis A and hepatitis B viruses.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Twinrix™ Junior TARGET	Twinrix™ Junior	GlaxoSmithKline	phase 3	Inactivated viral vaccine (combination)	Hepatitis A virus and Hepatitis B surface antigen
Twinrix™ Adult	Twinrix™ Adult	GlaxoSmithKline	phase 3	Inactivated viral vaccine (combination)	Hepatitis A virus antigen; Hepatitis B surface antigen (HBsAg)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated viral vaccine (combination) class)

GlaxoSmithKline · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Twinrix™ Junior — Competitive Intelligence Brief. https://druglandscape.com/ci/twinrix-junior. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab